Cellular inactivation induced by a radiopharmaceutical kit: role of stannous chloride

Assis, ML; Caceres, MR; De Mattos, JC; Caldeira-De-Araújo, A; Bernardo-Filho, M

HERO ID

4850040

Reference Type

Journal Article

Year

1998

Language

English

PMID

9862286

HERO ID 4850040
In Press No
Year 1998
Title Cellular inactivation induced by a radiopharmaceutical kit: role of stannous chloride
Authors Assis, ML; Caceres, MR; De Mattos, JC; Caldeira-De-Araújo, A; Bernardo-Filho, M
Journal Toxicology Letters
Volume 99
Issue 3
Page Numbers 199-205
Abstract Stannous chloride (SnCl2) has been used in many sectors of human activities such as food manufacturing and in nuclear medicine to produce radiopharmaceuticals labeled with technetium-99m (99mTc). Due to its importance and genotoxic potentiality, we decided to evaluate the biological effect induced by a nuclear medicine kit, which includes SnCl2, in association with glucoheptonic acid (GHA) which is employed for brain and renal scintigraphies. These studies were carried out with the Escherichia coli AB1157 strain and the deoxyribonucleic acid (DNA) plasmid pUC 9.1. The experiments, with different concentrations of SnCl2 and GHA, show an inverse relationship between both agents. When the GHA concentration was increased, the cellular inactivation induced by SnCl2 was reduced, as measured by the number of viable cells. Moreover, GHA protects the DNA molecule against the damage induced by SnCl2.
Doi 10.1016/S0378-4274(98)00221-5
Pmid 9862286
Url http://www.sciencedirect.com/science/article/pii/S0378427498002215
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English
Keyword Stannous chloride; Glucoheptonic acid; Technetium-99m; Plasmid DNA